United Kingdom

People: Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

22 Mar 2019
Change (% chg)

$-4.31 (-3.34%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gray, Nancy 

Dr. Nancy Ryan Gray, Ph.D., is Independent Director of the Company. Dr. Gray has acted as the President and CEO of Gordon Research Conferences, a nonprofit organization focused on organizing international scientific conferences, since 2003. From December 1997 until August 2003 she served as the Director of Membership for the American Chemical Society. Prior to that, Dr. Gray worked as a Senior Research Scientist at Exxon/Mobil Research and Engineering, a subsidiary of Exxon Mobil Corporation focused on researching oil and gas. Dr. Gray is a Fellow of the Royal Society of Chemistry, a Fellow of the American Association for the Advancement of Science and a member of the American Chemical Society. She was a Research Fellow at the Foundation on Matter Institute for Atomic and Molecular Physics in Amsterdam, and completed the Harvard Executive Education Finance for Senior Executives program. She also has authored or co-authored numerous scientific articles. Dr. Gray received her B.S. in Chemistry from the University of Notre Dame in 1981 and her Ph.D. in Fuel Science from The Pennsylvania State University in 1985. In selecting Dr. Gray to serve as a director, the board considered, among other things, her scientific background and knowledge of the biotechnology industry.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 115,275
Long-Term Incentive Plans, USD --
All Other, USD 245,357
Fiscal Year Total, USD 360,632

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kozarich


Matthew Foehr


John Higgins


Matthew Korenberg


Charles Berkman


Jason Aryeh

As Of  31 Dec 2017